Dr Reddy's Laboratories Ltd has signed a licensing agreement with US-based Ingenus Pharmaceuticals to commercialize Cyclophosphamide injection for cancer treatment. Dr Reddy's USA will commercialize the injection in the US market, paying Ingenus 50% of the calculated profit share.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/w6SFzTY
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Dr Reddy's signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injection
0 comments:
Post a Comment